Advances in Interventional Cardiology
eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2025
vol. 21
 
Share:
Share:
Image in intervention

Fusion imaging with heart navigator for precision-guided alcohol septal ablation in hypertrophic cardiomyopathy

Mariusz Skowerski
1
,
Piotr Pysz
2
,
Wojciech Wojakowski
2
,
Grzegorz Smolka
1

  1. Department of Cardiology, School of Health Sciences, Medical University of Silesia, Katowice, Poland
  2. Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
Adv Interv Cardiol 2025; 21, 2 (80): 282–283
Online publish date: 2025/05/30
Article file
- Fusion imaging (1).pdf  [0.18 MB]
Get citation
 
 

Despite the advent of myosin inhibitors resulting in the growing role of pharmacotherapy, the treatment options for symptomatic patients with hypertrophic cardiomyopathy and left ventricular outflow tract obstruction (LVOTO) still include alcohol ablation of the interventricular septum (IVS) [1]. Precise identification of the target coronary artery branch is necessary to limit the muscle scarring to the region responsible for LVOTO. Typically, one of the proximal septal branches of the anterior descending artery proves appropriate but, in some cases, identifying the correct one requires sequential contrast administration to several neighboring branches [2, 3].

We present the applicability of fusion imaging with the Heart Navigator system, allowing the transesophageal echocardiography (TEE) marker to be superimposed on the angiographic image for precise selection of the ablation vessel.

First, the part of the proximal segment of the IVS along which the greatest color Doppler flow turbulence occurs is identified by TEE biplanar imaging. This area is marked with a marker (Figure 1 A), which is simultaneously displayed on the corresponding angiographic image (Figure 1 B). The septal branch pointing towards the marker is then selectively catheterized using an over-the-wire balloon catheter with a diameter appropriate for the vessel size (in the present case, a 2 mm balloon catheter). After inflating the balloon, angiographic contrast agent is injected through the central lumen of the balloon catheter to confirm the proper identification of the vessel (opacification of the target IVS area is also visible on TEE). Finally, a suitable amount of absolute alcohol is introduced into the central lumen of the balloon catheter to perform myocardial ablation. Figures 1 C and D show the coronarography before and after the procedure.

Figure 1

A – TEE of proximal segment of the IVS along which the greatest color Doppler flow turbulence occurs, B – marker from TEE simultaneously displayed on the corresponding angiographic image, C – coronarography before procedure, D – coronarography after procedure

/f/fulltexts/PWKI/56178/PWKI-21-2-56178-g001_min.jpg

The presented method of fusion imaging allows one to conveniently combine, in one real-time image, the echocardiographic identification of the IVS subsegment responsible for LVOTO with the angiographic selection of the delivering septal branch.

Ethical approval

Not applicable.

Conflict of interest

The authors declare no conflict of interest.

References

1 

Maurizi N, Antiochos P, Owens A, et al. Long-term outcomes after septal reduction therapies in obstructive hypertrophic cardiomyopathy: insights from the SHARE Registry. Circulation 2024; 150: 1377–90.

2 

Bytyci I, Nistri S, Morner S, Henein MY. Alcohol septal ablation versus septal myectomy treatment of obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis. J Clin Med 2020; 9: 3062.

3 

Maron BJ, Rowin EJ, Casey SA, Maron MS. How hypertrophic cardiomyopathy became a contemporary treatable geneticdisease with low mortality: shaped by 50 years of clinical research and practice. JAMA Cardiol 2016; 1: 98–105.

Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.